Announcements Trials

Browse Landscape

Phase

Status

Completed 18 Recruiting 7 Terminated 5 Not yet recruiting 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 19 Prostatic Neoplasms 9 Breast Neoplasms 9 Melanoma 8 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Solid Tumors 4 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Mesothelioma 2 Lymphoma, T-Cell 2 Liver Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × INDUSTRY × Cachexia × Clear all

NCT04001010 2021-02-05

SERENITY

Tetra Bio-Pharma

Phase 3 Suspended

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡